Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study.

  title={Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study.},
  author={Paul T. Finger and Yana P Gelman and Anthony M. Berson and Andrzej Szechter},
  journal={The British journal of ophthalmology},
  volume={87 12},
AIM To report 7 year results of ophthalmic plaque radiotherapy for exudative macular degeneration. METHODS In a phase I clinical trial, 30 patients (31 eyes) were treated with ophthalmic plaque irradiation for subfoveal exudative macular degeneration. Radiation was delivered to a mean 2 mm from the inner sclera (range 1.2-2.4) prescription point calculated along the central axis of the plaque. The mean prescription dose was 17.62 Gy (range 12.5-24) delivered over 34 hours (range 18-65). Early… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 12 extracted citations

Epimacular brachytherapy — old ghost or new age?

Graefe's Archive for Clinical and Experimental Ophthalmology • 2011


Publications referenced by this paper.
Showing 1-10 of 50 references

Strontium plaque radiotherapy for exudative age - related macular degeneration

IJ Immonen, A Jaakaola, D Tommila
Invest Ophthalmol Vis Sci • 2001

Brachytherapy for macular degeneration associated with subretinal neovascularization

G Richard, RH Sagerman
Age - related macular degeneration : current treatment and concepts • 2000

Similar Papers

Loading similar papers…